Hubei Goto Biopharm Co.,Ltd.
SZSE:300966.SZ
21.06 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||
| Net Income
| 21.29 | 39.496 | 78.066 | 53.195 | 72.996 | 70.678 | 47.439 |
| Depreciation & Amortization
| 28.207 | 27.231 | 23.358 | 21.183 | 17.034 | 15.147 | 9.618 |
| Deferred Income Tax
| -5.41 | -8.083 | -5.387 | 0.37 | -1.005 | -0.662 | 0.693 |
| Stock Based Compensation
| 1.689 | 0 | 0 | 0 | 0 | 0 | 3.274 |
| Change In Working Capital
| -13.727 | -109.665 | -54.911 | -71.771 | -98.975 | -140.773 | -89.377 |
| Accounts Receivables
| -60.595 | -34.655 | 20.234 | -66.3 | -79.67 | -66.791 | -57.756 |
| Inventory
| -9.764 | -60.428 | -173.334 | 43.006 | -49.499 | -92.421 | -4.172 |
| Accounts Payables
| 62.042 | -6.499 | 103.575 | -48.848 | 31.198 | 19.101 | -28.142 |
| Other Working Capital
| 1.689 | -8.083 | -5.387 | 0.37 | -1.005 | -48.352 | -85.205 |
| Other Non Cash Items
| 16.499 | 18.902 | 11.492 | 10.868 | 17.447 | 7.056 | 10.261 |
| Operating Cash Flow
| 68.133 | -24.037 | 58.004 | 13.475 | 8.502 | -47.893 | -22.06 |
| Investing Activities: | |||||||
| Investments In Property Plant And Equipment
| -409.255 | -407.94 | -90.876 | -18.567 | -33.27 | -13.909 | -19.67 |
| Acquisitions Net
| 19.6 | 0.133 | 16.32 | 5.448 | 0.01 | 0.004 | 0.007 |
| Purchases Of Investments
| 0 | -33.6 | -14.4 | -5.448 | -0.01 | 0 | 0 |
| Sales Maturities Of Investments
| 0.009 | 0 | -16.32 | 0 | 0.189 | 0.237 | 0.061 |
| Other Investing Activites
| 6.898 | -14.898 | -0.137 | 0.048 | 0.01 | 15.304 | -15.293 |
| Investing Cash Flow
| -402.348 | -456.304 | -105.413 | -18.519 | -33.071 | 1.632 | -34.903 |
| Financing Activities: | |||||||
| Debt Repayment
| -3.316 | -250.445 | -156.765 | -161.569 | -114.427 | -85.59 | -33 |
| Common Stock Issued
| 0 | 0 | -13.978 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 13.978 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -6.094 | -15.678 | -7.576 | -9.164 | -9.265 | -4.621 | -3.306 |
| Other Financing Activities
| 18.371 | 990.648 | 371.343 | 140.291 | 195.42 | 140.932 | 94.009 |
| Financing Cash Flow
| 15.593 | 713.296 | 207.002 | -30.442 | 71.728 | 50.721 | 57.703 |
| Other Information: | |||||||
| Effect Of Forex Changes On Cash
| -0.321 | 0.278 | -0.437 | 0.065 | -0.713 | -0.162 | -0.259 |
| Net Change In Cash
| -318.944 | 233.233 | 159.156 | -35.421 | 46.447 | 4.298 | 0.482 |
| Cash At End Of Period
| 96.206 | 415.15 | 181.917 | 22.76 | 58.182 | 11.735 | 7.437 |